Business Context and Reporting Period
This Form 8-K Current Report was filed by Establishment Labs Holdings Inc. on January 28, 2021. The Company is incorporated in the British Virgin Islands and its common shares trade on the NASDAQ Capital Market under the symbol "ESTA". The report addresses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a specific event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the resignation of David Hung from the Board of Directors and all associated committees. The resignation is effective February 11, 2021. The departure is attributed to Dr. Hung limiting his public board commitments in anticipation of the public trading of Nuvation Bio, Inc., where he serves as Chief Executive Officer. The Company explicitly states that the resignation does not result from any disagreement regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No new risks, contingencies, or unusual items are disclosed in this specific report.
Key Facts for Investor Verification
- David Hung resigned as a Director effective February 11, 2021.
- The resignation is voluntary and unrelated to any dispute with the Company.
- The departure is linked to Dr. Hung's role as CEO of Nuvation Bio, Inc.
- The Company is classified as an emerging growth company.